10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒     QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2021

or

☐     TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ____ to ____.

Commission File Number

Integrated Cannabis Solutions, Inc.

(Exact name of small business issuer as specified in its charter)

Nevada	90-1505708
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

6810 North State Road 7

Coconut Creek, Florida 33073

(Address of principal executive offices)

(954) 906-0098

(Company’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒   No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒   No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☒
(Do not check if a smaller reporting company)		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒   No ☐

The Company has 1,533,317,059 common stock shares outstanding as of November 11, 2021.

TABLE OF CONTENTS

		Page
PART I — FINANCIAL INFORMATION		F-1
ITEM 1.	Unaudited Consolidated Financial Statements	F-1
ITEM 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	3
ITEM 3.	Quantitative and Qualitative Disclosures about Market Risk	7
ITEM 4.	Controls and Procedures	7
PART II — OTHER INFORMATION
ITEM 1.	Legal Proceedings	8
ITEM 1A.	Risk Factors	8
ITEM 2.	Unregistered Sales of Equity Securities and Use of Proceeds	8
ITEM 3.	Defaults Upon Senior Securities	8
ITEM 4.	Mine Safety Disclosures	8
ITEM 5.	Other Information	8
ITEM 6.	Exhibits	9
	Signatures	11

2

PART I – FINANCIAL INFORMATION

ITEM 1. Consolidated Financial Statements (Unaudited)

INTEGRATED CANNABIS SOLUTIONS,  INC.

INDEX TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

Condensed Consolidated Balance Sheets (unaudited)	F-2
Condensed Consolidated Statements of Operations (unaudited)	F-3
Condensed Consolidated Statements of Stockholders’ Deficit (unaudited)	F-4
Condensed Consolidated Statements of Cash Flows (unaudited)	F-5
Notes to the Condensed Consolidated Financial Statements (unaudited)	F-6

F-1

INTEGRATED CANNABIS SOLUTIONS, INC. AND SUBSIDIARY

UNAUDITED CONSOLIDATED BALANCE SHEETS

	September 30,			December 31,
	2021			2020
ASSETS
current assets
Prepaid expenses	$	10,000		$	3,000
Total assets	$	10,000		$	3,000
LIABILITIES, TEMPORARY EQUITY AND STOCKHOLDERS' DEFICIT
CURRENT Liabilities:
Accounts payable and accrued expenses	$	456,099		$	344,253
Notes payable		395,419			234,336
Advances from officer		136,168			110,504
Total Liabilities		987,686			689,093
Commitments and Contingencies (See Note 7)
Stockholders' deficit:
Preferred Series A stock, $0.0001 par value, 1,000,000 and 1,000,000 shares authorized, 992,400 and 993,400 issued and outstanding, respectively		99			100
Preferred Series B stock, $0.0001 par value, 600,000 and 600,000 shares authorized, no shares issued and outstanding, respectively		-			-
Preferred Series C stock, $0.0001 par value, 540,000 and 540,000 shares authorized, 540,000 and 540,000 shares issued and outstanding, respectively		54			54
Common stock, $0.0001 par value, 1,650,000,000 and 1,650,000,000 shares authorized, 1,533,317,059 and 1,483,317,059 shares issued and outstanding, respectively		153,332			148,332
Additional paid-in capital		2,619,845			2,624,844
Accumulated deficit		(3,751,016	)		(3,459,423	)
Total Stockholders' Deficit		(977,686	)		(686,093	)
Total liabilities, TEMPORARY EQUITY and stockholders' deficit	$	10,000		$	3,000

The accompanying footnotes are an integral part of these unaudited consolidated financial statements.

F-2

INTEGRATED CANNABIS SOLUTIONS, INC. AND SUBSIDIARY

UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS

	For the Three months Ended September 30,						For the Nine months Ended September 30,
	2021			2020			2021			2020
Revenue	$	-		$	-		$	-		$	-
Operating expenses:
Salaries and wages		45,000			45,000			135,000			135,000
Selling, general and administrative		6,642			1,950			20,730			6,963
Professional and legal fees		29,354			-			102,533			70,631
Total operating expenses		80,996			46,950			258,263			212,594
Loss from operations		(80,996	)		(46,950	)		(258,263	)		(212,594	)
Other expense:
Interest expense		(13,067	)		(6,645	)		(33,330	)		(17,766	)
Total other expense		(13,067	)		(6,645	)		(33,330	)		(17,766	)
Net loss	$	(94,063	)	$	(53,595	)	$	(291,593	)	$	(230,360	)
Net loss per common share - basic and diluted	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.00	)
Weighted average number of shares outstanding - basic and diluted		1,533,317,059			1,337,142,196			1,500,533,176			1,196,382,752

The accompanying footnotes are an integral part of these unaudited consolidated financial statements.

F-3

INTEGRATED CANNABIS SOLUTIONS, INC. AND SUBSIDIARY

UNAUDITED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2021 AND 2020

	Common Stock				Preferred Stock Series A					Preferred Stock Series C				Additional						Total
	Shares		Amount		Shares			Amount		Shares		Amount		Paid-In Capital			Accumulated Deficit			Stockholders' Deficit
Balance at June 30, 2020		1,253,317,059	$	125,332		998,000		$	100		540,000	$	54	$	2,647,844		$	(3,290,005	)	$	(516,675	)
Preferred Stock Series A conversion to common		130,000,000		13,000		(2,600	)		-		-		-		(13,000	)		-			-
Net loss		-		-		-			-		-		-		-			(53,595	)		(53,595	)
Balance at September 30, 2020		1,383,317,059	$	138,332		995,400		$	100		540,000	$	54	$	2,634,844		$	(3,343,600	)	$	(570,270	)

	Common Stock				Preferred Stock Series A				Preferred Stock Series C				Additional					Total
	Shares		Amount		Shares		Amount		Shares		Amount		Paid-In Capital		Accumulated Deficit			Stockholders' Deficit
Balance at June 30, 2021		1,533,317,059	$	153,332		992,400	$	99		540,000	$	54	$	2,619,845	$	(3,656,953	)	$	(883,623	)
Net loss		-		-		-		-		-		-		-		(94,063	)		(94,063	)
Balance at September 30, 2021		1,533,317,059	$	153,332		992,400	$	99		540,000	$	54	$	2,619,845	$	(3,751,016	)	$	(977,686	)

The accompanying footnotes are an integral part of these unaudited consolidated financial statements.

F-4

INTEGRATED CANNABIS SOLUTIONS, INC. AND SUBSIDIARY

UNAUDITED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2021 AND 2020

	Common Stock				Preferred Stock Series A					Preferred Stock Series C				Additional						Total
	Shares		Amount		Shares			Amount		Shares		Amount		Paid-In Capital			Accumulated Deficit			Stockholders' Deficit
Balance at December 31, 2019		1,153,317,059	$	115,332		1,000,000		$	100		540,000	$	54	$	2,657,844		$	(3,113,240	)	$	(339,910	)
Preferred Stock Series A conversion to common		230,000,000		23,000		(4,600	)		-		-		-		(23,000	)		-			-
Net loss		-		-		-			-		-		-		-			(230,360	)		(230,360	)
Balance at September 30, 2020		1,383,317,059	$	138,332		995,400		$	100		540,000	$	54	$	2,634,844		$	(3,343,600	)	$	(570,270	)

	Common Stock				Preferred Stock Series A						Preferred Stock Series C				Additional						Total
	Shares		Amount		Shares			Amount			Shares		Amount		Paid-In Capital			Accumulated Deficit			Stockholders' Deficit
Balance at December 31, 2020		1,483,317,059	$	148,332		993,400		$	100			540,000	$	54	$	2,624,844		$	(3,459,423	)	$	(686,093	)
Preferred Stock Series A conversion to common		50,000,000		5,000		(1,000	)		(1	)		-		-		(4,999	)		-			-
Net loss		-		-		-			-			-		-		-			(291,593	)		(291,593	)
Balance at September 30, 2021		1,533,317,059	$	153,332		992,400		$	99			540,000	$	54	$	2,619,845		$	(3,751,016	)	$	(977,686	)

The accompanying footnotes are an integral part of these unaudited consolidated financial statements.

F-5

INTEGRATED CANNABIS SOLUTIONS, INC. AND SUBSIDIARY

UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS

	For the Nine months Ended September 30,
	2021			2020
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$	(291,593	)	$	(230,360	)
Adjustment to reconcile net loss to net cash used in operating activities:
Change in operating assets and liabilities:
Prepaid expenses		(7,000	)		-
Accounts payable and accrued expenses		111,846			147,432
Net cash used in operating activities		(186,747	)		(82,928	)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of notes payable		161,083			59,713
Advances from officer		25,664			23,215
Net cash provided by financing activities		186,747			82,928
NET CHANGE IN CASH		-			-
Cash at beginning of year		-			-
CASH AT END OF YEAR	$	-		$	-
SUPPLEMENTAL DISCLOSURE FOR OPERATING ACTIVITIES:
Cash paid for interest	$	-		$	-
Cash paid for income taxes	$	-		$	-
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Preferred Stock Series A conversion to common stock	$	5,000		$	23,000

The accompanying footnotes are an integral part of these unaudited consolidated financial statements.

F-6

INTEGRATED CANNABIS SOLUTIONS, INC. AND SUBSIDIARY

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 – INCORPORATION AND OPERATIONS

Integrated Cannabis Solutions, Inc. (the “Company”) is a Nevada corporation quoted  on OTC Markets Pink under the ticker "IGPK" . The Company was formed on December 31, 2003 and had nominal operations during the years ended December 31, 2020 and 2019.

The Company plans to process hemp or biomass into Cannabidiol (“CBD”) by establishing a processing plant in Wisconsin to supply manufacturers or pharmaceutical companies for their manufacture, distribution and sale of CBD related products such as edibles for human consumption, vitamins, and multi-vitamins, and topical products for human use such as oils, tinctures, creams, oils and salves, and vaping liquids. The Company also plans to promote and assist in the establishment of a co-op with local farmers for the purpose of establishing a consistent supply of biomass and enter into long term supply contracts.

On May 21, 2019, the Company formed Integrated Farming Solutions, LLC,  a limited liability company in Nevada. Integrated Farming Solutions, LLC is the Company’s wholly-owned subsidiary and has not yet begun operations. No assurance can be provided that the Company will be successful in implementing and executing on its business plans.

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION

The accompanying unaudited interim consolidated financial statements of Integrated Cannabis Solutions, Inc. (the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America and should be read in conjunction with the audited financial statements and notes thereto. In the opinion of management, such statements reflect all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of the condensed financial statements of the Company as of September 30, 2021 and for the three and nine months ended September 30, 2021 and 2020. The results of operations for the nine months ended September 30, 2021 are not necessarily indicative of the results to be expected for the full year the full year ending December 31, 2021 or any other period. These unaudited condensed financial statements should be read in conjunction with the audited financial statements and related disclosures of the Company as of December 31, 2020 and for the year then ended.

The accompanying unaudited interim condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiary. All intercompany balances and transactions have been eliminated in consolidation.

Accounting method and use of estimates

The Company’s financial statements are prepared using the accrual method in accordance with Generally Accepted Accounting Principles in the United State of America (“GAAP”). The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Changes in estimates and assumptions are reflected in reported results in the period in which they become known. Significant estimates made by management include, but are not limited to, valuation of stock options, stock-based compensation, convertible debt and the valuation allowance associated with deferred tax assets. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. Actual results could differ from those estimates.

F-7

INTEGRATED CANNABIS SOLUTIONS, INC. AND SUBSIDIARY

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

Loss per Share

In accordance with the provisions of ASC 260, “Earnings Per Share”, net loss per share is computed by dividing net loss by the weighted-average shares of common stock outstanding during the period. During a loss period, the effect of the potential exercise of stock options and convertible debt are not considered in the diluted loss per share calculation since the effect would be anti-dilutive. The results of operations were a net loss for the three and nine months ended September 30, 2021 and 2020, therefore, the basic and diluted weighted-average shares of common stock outstanding were the same for all years. The anti-dilutive shares of common stock outstanding as of September 30, 2021 and 2020 were as follows:

	September 30,
	2021		2020
Potentially dilutive securities:
Series A Preferred Stock		49,670,000,000		49,900,000,000
Series C Preferred Stock		137,755,102		446,280,992

Recent Accounting Pronouncements

The Company has implemented all new accounting pronouncements that are in effect and that may impact its consolidated financial statements. The Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

NOTE 3 – GOING CONCERN

At September 30, 2021, the Company had a working capital deficit of $977,686 and has yet to commence its plan of operations. The Company’s current liquidity resources are insufficient to fund its anticipated level of operations for at least the next 12 months from the date these financial statements were issued. As a result, there is substantial doubt regarding the Company’ ability to continue as a going concern.

The Company’s ability to continue operations depends on its ability to generate and grow revenue and results of operations as well as its ability to access capital markets when necessary to accomplish its strategic objectives. The Company expects that it will continue to incur losses for the immediate future and will need additional equity or debt financing until the Company can achieve profitability and positive cash flows from operating activities. The Company’s future capital requirements for its operations will depend on many factors, including the ability to generate revenues and its ability to obtain capital. There is no assurance that the Company will be successful in any capital-raising efforts that it may undertake to fund operations and implement its business plan in the future.

NOTE 4 – ACCOUNTS PAYABLE AND ACCRUED EXPENSES

As of September 30, 2021 and December 31, 2020, accounts payable and accrued expenses consisted of the following:

	September 30,		December 31,
	2021		2020
Accounts payable	$	16,826	$	73,310
Accrued payroll		365,000		230,000
Accrued interest payable		74,273		40,943
Total	$	456,099	$	344,253

F-8

INTEGRATED CANNABIS SOLUTIONS, INC. AND SUBSIDIARY

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 5 – RELATED PARTY TRANSACTIONS

The Company’s Chief Executive Officer (“CEO”) advanced $25,664 by paying expenses on behalf of the Company during the nine months ended September 30, 2021 for working capital purposes. The Company accrues $500 per month for rent and use of the CEO’s office space. The loans bear interest at 10% per annum and are payable on demand. The balance of the loans were $136,168 and $110,504 and accrued interest was $26,010 and $17,168 as of September 30, 2021 and December 31, 2020, respectively. Interest expense was $8,843 and $6,955 for the nine months ended September 30, 2021 and 2020, respectively.

NOTE 6 – NOTES PAYABLE

During the nine months ended September 30, 2021, a third party lender advanced a total of $153,583 for working capital purposes under a demand note. The advances accrue interest at 10% per annum and are due on demand. The balance on the note was $387,919 and $234,336 and accrued interest was $47,819 and $23,775 as of September 30, 2021 and December 31, 2020, respectively. Interest expense was $24,043 and $10,810 for the nine months ended September 30, 2021 and 2020, respectively.

During the nine months ended September 30, 2021, a third party lender advanced a total of $7,500 for working capital purposes under a demand note. The advance accrues interest at 10% per annum and is due on demand. The balance on the note was $7,500 and accrued interest was $444 as of September 30, 2021. Interest expense was $444 for the nine months ended September 30, 2021.

NOTE 7 – COMMITMENTS AND CONTINGENCIES

The Company from time to time is party to certain lawsuits, legal proceedings and various claims relating to matters in the normal course of its business. Liabilities for such matters are accrued when it is probable that a liability has been incurred and the amount can be reasonably estimated. When only a range of possible loss can be established, the most probable amount in the range is accrued. If no amount within this range is a better estimate than any other amount within the range, the minimum amount in the range is accrued. The accrual for a litigation loss contingency might include, for example, estimates of potential damages, outside legal fees and other directly related costs expected to be incurred. As of September 30, 2021, and through the date these financial statements were issued, there were no legal proceedings requiring recognition or disclosure in the unaudited condensed consolidated financial statements.

On January 1, 2018, the Company entered into an employment agreement with the CEO. Under the terms of the employment agreement, the Company was to pay the CEO a salary at a rate of $180,000 for the 2018 calendar year, $300,000 for the 2019 calendar year, and $500,000 for the 2020 calendar year. On December 31, 2019, the CEO’s salary was reduced to $180,000 per year effective on January 1, 2020 and the aggregate of previously accrued wages were reduced to $50,000 in total.

The Company has accrued $365,000 and $230,000 as of September 30, 2021 and December 31, 2020, respectively, and recognized $135,000 and $135,000 in wage expense for the nine months ended September 30, 2021 and 2020, respectively.

On February 23, 2021, the Company and our Chief Executive Officer were served with a Complaint in the Superior Court for Sacramento, California alleging negligence and premises liability by over 100 persons and entities. The complaint has no merit and we intend to vigorously defend the matter. 

NOTE 8 – COMMON STOCK

During the nine months ended September 30, 2021 and 2020, a holder of 1,000 and 2,000 shares of our Preferred Series A stock converted those shares into 50,000,000 and 100,000,000 shares of the Company’s common stock, respectively.

NOTE 9 – SUBSEQUENT EVENTS

The Company has evaluated subsequent events for financial statement purposes, there were none occurring through the date these financial statements were ready for issuance, that require disclosure in these consolidated financial statements.

F-9

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Overview

We were originally incorporated on October 9, 1995 in Texas under the name, Posh International, Inc.. On December 31, 2003, we changed our domicile from Texas to Nevada.

Our headquarters are in Coconut Creek, FL. We have experienced recurring losses and negative cash flows from operations since inception, including in our current business model. We anticipate that our expenses will increase as we ramp up our expansion, which likely will lead to additional losses, until such time that we approach profitability, or which there are no assurances. We have relied on equity and debt financing to fund operations. There can be no guarantee that we will ever become profitable, or that adequate additional financing will be realized in the future or otherwise may be available to us on acceptable terms, or at all. If we are unable to raise capital when needed, we would be forced to delay development of our operations. We will need to generate significant revenues to achieve profitability, of which there are no assurances.

Trends and Uncertainties

Our business is subject to the following trends and uncertainties:

· State and Federal laws regarding growing and processing industrial hemp; currently hemp is legal to be grown in all 50 States pursuant to the 2018 Farm Act signed into law in July of 2018.

· With the passing of the Farm Act, more growers have entered the market causing the price of refined hemp to drop; we believe this will continue to drop for another year before the market stabilizes

· Testing requirements have and will continue to evolve meaning less Biomass maybe available to refine designated as pharmaceutical grade

· Weather is a major factor, with wild climate swings taking place this could also cause a shortage in available Biomass.

Going Concern 

At September 30, 2021, we had a working capital deficit of $977,686. To date, we have yet to commence our Plan of Operations and continue to rely on advances from our officer to continue our day-to-day activities. As a result, there is substantial doubt regarding our ability to continue as a going concern. Our ability to continue operations depends on our ability to generate and grow revenue and results of operations as well as our ability to access capital markets when necessary to accomplish our strategic objectives.

We expect that we will continue to incur losses for the immediate future and will need additional equity or debt financing until we can achieve profitability and positive cash flows from operating activities. Our future capital requirements for our operations will depend on many factors, including the ability to generate revenues and our ability to obtain capital. There is no assurance that we will be successful in any capital-raising efforts that we may undertake to fund our operations and implement our business plan

Our plans to implement our Plan of Operations include the following:

· Renting space in an area in Wisconsin where we can setup a processing lab to  processing some of the Biomass harvested during 2019.

· Once the processing lab is set up, we will meet with farmers in the area growing hemp and seek to form a co-op with them, where they farm the crop, and we process the crop and sell the Isolate.

The foregoing goals will increase expenses and lead to possible net losses. There is no assurance that we will ever be profitable or that debt or equity financing will be available to us. The consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result should we be unable to continue as a going concern. There is no assurance we will be successful in any of these goals.

3

Results of Operations

The following information should be read in conjunction with the financial statements and notes appearing elsewhere in this Report. We have not generated any revenues from inception to date. We anticipate that we may not receive any significant revenues from operations until we begin our planned operations to process hemp or biomass into Cannabidiol (“CBD”) by establishing a processing plant in Wisconsin to supply manufacturers or pharmaceutical companies for their manufacture, distribution and sale of CBD related products such as edibles for human consumption, vitamins, and multi-vitamins, and topical products for human use such as oils, tinctures, creams, oils and salves, and vaping liquids. We also plan to promote and assist in the establishment of a co-op with local farmers for the purpose of establishing a consistent supply of biomass and enter into long term supply contracts.

For the Three Months Ended September 30, 2021 and September 30, 2020

Revenues

We had no revenues for the three months ended September 30, 2021 and 2020.

Operating Expenses

Our operating expenses for three months ended September 30, 2021 and 2020 totaled $80,996 and $46,950, respectively. The $34,046 increase in our operating expenses is due to a $29,354 increase in professional and legal fees and a $4,692 increase in general and administrative expenses compared to the 2020 period.

Other Income and Expenses

Total other expenses consisted of interest expense of $13,067 and $6,645 for the three months ended September 30, 2021 and 2020, respectively.

Net Loss

We recognized net losses of $94,063 and $53,595 for the three months ended September 30, 2021 and 2020, respectively. The net losses are due to the $80,996 and $46,950 in operating expenses, as well as the $13,067 and $6,645 in other expenses for years ended three months ended September 30, 2021 and 2020, respectively, as discussed above.

We anticipate losses from operations will increase during the next twelve months due to anticipated increased payroll expenses as we add necessary staff and increases in legal and accounting expenses associated with maintaining a reporting company. We expect that we will continue to have net losses from operations for several years until revenues from operating facilities become sufficient to offset operating expenses.

For the Nine Months Ended September 30, 2021 and September 30, 2020

Revenues

We had no revenues for the nine months ended September 30, 2021 and 2020.

4

Operating Expenses

Our operating expenses for nine months ended September 30, 2021 and 2020 totaled $258,263 and $212,594, respectively. The $45,669 increase in operating expenses is due to a $31,902 increase in professional and legal fees and a $13,767 increase in general and administrative expenses compared to the 2020 period.

Other Income and Expenses

Total other expenses consisted of interest expense of $33,330 and $17,766 for the nine months ended September 30, 2021 and 2020, respectively.

Net Loss

We recognized net losses of $291,593 and $230,360 for the nine months ended September 30, 2021 and 2020, respectively. The net losses are due to the $258,263 and $212,594 in operating expenses, as well as the $33,330 and $17,766 in other expenses for nine months ended September 30, 2021 and 2020, respectively, as discussed above.

We anticipate losses from operations will increase during the next twelve months due to anticipated increased payroll expenses as we add necessary staff and increases in legal and accounting expenses associated with maintaining a reporting company. We expect that we will continue to have net losses from operations for several years until revenues from operating facilities become sufficient to offset operating expenses.

Liquidity and Capital Resources

We have generated no revenues since inception. We have obtained cash for operating expenses mainly through advances and/or loans from affiliates and stockholders.

At September 30, 2021, we had a working capital deficit of $977,686 and have yet to commence our plan of operations. Our current liquidity resources are not sufficient to fund our anticipated level of operations. As a result, there is substantial doubt regarding our ability to continue as a going concern. Our ability to continue operations depends on our ability to generate and grow revenue as well as access capital markets when necessary to fund strategic objectives. We expect to continue to incur losses for the immediate future and will need additional equity or debt financing until we can achieve profitability and positive cash flows from operating activities. There is no assurance that the Company will be successful in any capital-raising efforts that it may undertake to fund operations and implement our business plan in the future.

Net Cash Used in Operating Activities.

During the nine months ended September 30, 2021 and 2020, our net cash used in operating activities was $186,747 and $82,928, respectively. Cash flows used from operations mainly consists of net losses of $291,583 and $230,360 as discussed above, as well as an increase of $7,000 and $0 in prepaid expenses, partially offset by decreases of $111,846 and $147,432 in accounts payable and accrued expenses during the nine months ended September 30, 2021 and 2020, respectively. Our primary uses of funds in operations were payments made for legal and professional costs.

Net Cash Provided by Investing Activities.

We had no cash investing activities during the nine months ended September 30, 2021 and 2020.

Net Cash Provided by Financing Activities.

Net cash provided by financing activities during the three months ended September 30, 2021 and 2020 totaled $186,747 and $82,928, respectively. We received $25,664 and $23,215 in officer advances and $161,083 and $59,713 in proceeds from issuance of notes payable during the nine months ended September 30, 2021 and 2020, respectively.

5

Cash Position and Outstanding Indebtedness.

Our total indebtedness at September 30, 2021 and December 31, 2020 was $987,686 and $689,083, respectively, all of which are considered current liabilities. Current liabilities consist primarily of accounts payable and accrued expenses, advances from officer and notes payable.

At September 30, 2021 and December 31, 2020, we had $10,000 and $3,000 current assets and our working capital deficit was $977,686 and $686,093, respectively.

Off-Balance Sheet Arrangements

We have not and do not have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of establishing off-balance sheet arrangements or other contractually narrow or limited purposes. Therefore, we do not believe we are exposed to any financing, liquidity, market or credit risk that could arise if we had engaged in such relationships.

The following discussion should be read in conjunction with our consolidated financial statements and the related notes. The following discussion contains forward-looking statements that reflect our plans, estimates and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements.

Plan of Operations

Once we commence our plan of operations, we anticipate that we will incur approximately $2.1 million of total expenses during the initial 12 months, including hiring personnel, purchasing lab equipment, and training over the first three months of our operations at a burn rate of $54,550 per month. During months 4 to 12 of our Plan of Operations, our burn rate is estimated at $232,216 per month. Based on our current working capital deficit and our absence of any historical revenues, we will have to rely on our sole officer and third-party financing to fund our operations. The initial 12-month Plan of Operations is contingent upon obtaining a minimum financing of at least $1,296,416.

There are no assurances that we will be able to obtain financing or on terms acceptable to us. Our Plan of Operations will begin four months after we receive financing, if ever. We have researched and identified the equipment needed to operate a plant capable of initially processing one acre per day that can be expanded to processing three to five acres per day; we have not yet purchased any equipment. We have not offered any services to local or out of state farmers at this time. It will take approximately four months to begin operations after the order and delivery of the processing equipment, after which we will introduce ourselves to the local farms in a hundred-mile radius around the plant, in an attempt to enter into multi-year processing agreements. We will also complete a website that will offer the finished product Isolate for sale by the liter and encourage buyers to enter into annual contracts for a minimum number of liters per month at a discount.

6

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

ITEM 4. CONTROLS AND PROCEDURES

EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES

We maintain disclosure controls and procedures that are designed to ensure the information required to be disclosed in our reports filed pursuant to the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission rules and forms and that such information is accumulated and communicated to our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

As of September 30, 2021, we carried out an evaluation, under the supervision and with the participation of our principal executive officer and our principal financial officer of the effectiveness of the design and operation of our disclosure controls and procedures. Based on this evaluation, our principal executive officer and our principal financial officer concluded that our disclosure controls and procedures were not effective as of the end of the period covered by this report.

The determination that our disclosure controls and procedures were not effective as of September 30, 2021 is a result of not having adequate staffing and supervision within the accounting operations of our Company. The Company plans to expand its accounting operations as the business of the Company expands.

MANAGEMENT’S QUARTERLY REPORT ON INTERNAL CONTROLS OVER FINANCIAL REPORTING CHANGES IN INTERNAL CONTROLS OVER FINANCIAL REPORTING

There have been no changes in our internal controls over financial reporting during the quarter ended September 30, 2021 that have materially affected or are reasonably likely to materially affect our internal controls.

7

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

On February 23, 2021, we and our Chief Executive Officer were served with a Complaint in the Superior Court for Sacramento, California alleging negligence and premises liability by over 100 persons and entities. The complaint has no merit and we intend to vigorously defend the matter.  

ITEM 1A RISK FACTORS

As a smaller reporting company, we are not required to include risk factors; however, our  S-1 Registration Statement contains various risk factors at the following link: https://www.sec.gov/Archives/edgar/data/1002771/000147793221003534/igpk_s1a.htm

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES

None

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

None. 

ITEM 4. MINING SAFETY DISCLOSURE

None. 

ITEM 5. OTHER INFORMATION

None. 

8

ITEM 6. EXHIBITS

Exhibit Number	Description
31.1	Certification of the Chief Executive Officer and Chief Financial Officer Pursuant to Rule 13a-14 or 15d-14 of the Exchange Act Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1	Certification of the Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C., Section 1350 as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002.
101.INS *	XBRL Instance Document
101.SCH*	XBRL Taxonomy Extension Schema Document
101.CAL*	XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*	XBRL Taxonomy Extension Label Linkbase Document
101.PRE*	XBRL Taxonomy Extension Presentation Linkbase Document

________________ 

*Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of the registration statement or prospectus for purposes of Sections 11 and 12 of the Securities Act of 1933 or Section 18 of the Securities Act of 1934 and otherwise are not subject to liability.

9

ITEM 6. Exhibits.

EXHIBIT INDEX

Exhibit Number	Description
31.1	Certifications of the Chief Executive Officer and Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2	Certifications of the Chief Executive Officer and Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1	Certification of the Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2	Certification of the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension Schema Document
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document
101.LAB	XBRL Taxonomy Extension Label Linkbase Document
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document

10

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	INTEGRATED CANNABIS SOLUTIONS,  INC.
Date: November 15, 2021	By:	/s/ Matt Dwyer
		Matt Dwyer
		Chief Executive Officer
		(Principal Executive Officer & Chief Executive Officer)

By:	/s/ Matt Dwyer
	Matt Dwyer
	Chief Financial Officer
	(Chief Financial Officer/Chief Accounting Officer)

11

EX-31.1

EXHIBIT 31.1

CERTIFICATION

CHIEF EXECUTIVE OFFICER

PURSUANT TO SECTION 302

OF THE SARBANES-OXLEY ACT OF 2002

I, Matt Dwyer, certify that:

1.	I have reviewed this Quarterly Report on Form 10-Q of Integrated Cannabis Solutions, Inc.;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrants’ other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)	All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 15, 2021	/s/ Matt Dwyer
	Matt Dwyer
	(Principal Executive Officer & Chief Executive Officer)

EX-31.2

EXHIBIT 31.2

CERTIFICATION

CHIEF FINANCIAL OFFICER/CHIEF ACCOUNTING OFFICER

PURSUANT TO SECTION 302

OF THE SARBANES-OXLEY ACT OF 2002

I, Matt Dwyer, certify that:

1.	I have reviewed this Quarterly Report on Form 10-Q of Integrated Cannabis Solutions, Inc.:
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrants’ other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)	All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 15, 2021	/s/ Matt Dwyer
	Matt Dwyer
	Chief Financial Officer/Chief Accounting Officer
	(Principal Financial Officer and Principal Accounting Officer)

EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), the undersigned officer of Integrated Cannabis Solutions, Inc. (the “Company”), does hereby certify, to such officer’s knowledge, that:

The Quarterly Report on Form 10-Q for the quarter ended September 30, 2021 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934 and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company as of, and for, the periods presented in the Form 10-Q.

Date: November 15, 2021	/s/ Matt Dwyer
	Matt Dwyer
	Principal Executive Officer/Chief Executive Officer
	(Principal Executive Officer and Chief Executive Officer)

EX-32.2

EXHIBIT 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), the undersigned officer of Integrated Cannabis Solutions, Inc. (the “Company”), does hereby certify, to such officer’s knowledge, that:

The Quarterly Report on Form 10-Q for the quarter ended September 30, 2021 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934 and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company as of, and for, the periods presented in the Form 10-Q.

Date: November 15, 2021	/s/ Matt Dwyer
	Matt Dwyer, Chief Financial Officer/Chief Accounting Officer
	(Principal Financial Officer/Chief Financial Officer/Principal Accounting Officer)

The foregoing certifications are being furnished as an exhibit to the Form 10-Q pursuant to Item 601(b)(32) of Regulation S-K and Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) and, accordingly, is not being filed as part of the Form 10-Q for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

XML

Cover - shares	9 Months Ended
	Sep. 30, 2021	Nov. 11, 2021
Cover [Abstract]
Entity Registrant Name	Integrated Cannabis Solutions, Inc.
Entity Central Index Key	0001002771
Document Type	10-Q
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Small Business	true
Entity Shell Company	true
Entity Emerging Growth Company	false
Entity Current Reporting Status	Yes
Document Period End Date	Sep. 30, 2021
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2021
Entity Common Stock Shares Outstanding		1,533,317,059
Document Quarterly Report	true
Document Transition Report	false
Entity Incorporation State Country Code	NV
Entity Tax Identification Number	90-1505708
Entity Address Address Line 1	6810 North State Road 7
Entity Address City Or Town	Coconut Creek
Entity Address State Or Province	FL
Entity Address Postal Zip Code	33073
City Area Code	954
Local Phone Number	906-0098
Entity Interactive Data Current	Yes

XML

UNAUDITED CONSOLIDATED BALANCE SHEETS - USD ($)	Sep. 30, 2021	Dec. 31, 2020
current assets
Prepaid expenses	$ 10,000	$ 3,000
Total assets	10,000	3,000
CURRENT Liabilities:
Accounts payable and accrued expenses	456,099	344,253
Notes payable	395,419	234,336
Advances from officer	136,168	110,504
Total Liabilities	987,686	689,093
Stockholders' deficit:
Common stock, $0.0001 par value, 1,650,000,000 and 1,650,000,000 shares authorized, 1,533,317,059 and 1,483,317,059 shares issued and outstanding, respectively	153,332	148,332
Additional paid-in capital	2,619,845	2,624,844
Accumulated deficit	(3,751,016)	(3,459,423)
Total Stockholders' Deficit	(977,686)	(686,093)
Total liabilities, TEMPORARY EQUITY and stockholders' deficit	10,000	3,000
Series A Preferred Stock
Stockholders' deficit:
Preferred stock value	99	100
Series B Preferred Stock
Stockholders' deficit:
Preferred stock value	0	0
Series C Preferred Stock
Stockholders' deficit:
Preferred stock value	$ 54	$ 54

XML

UNAUDITED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Sep. 30, 2021	Dec. 31, 2020
Common Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Common Stock, Shares Authorized	1,650,000,000	1,650,000,000
Common Stock, Shares, Issued	1,533,317,059	1,483,317,059
Common Stock, Shares, Outstanding	1,533,317,059	1,483,317,059
Series A Preferred Stock
Preferred Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized	1,000,000	1,000,000
Preferred Stock, Shares Issued	992,400	993,400
Preferred Stock, Shares Outstanding	992,400	993,400
Series B Preferred Stock
Preferred Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized	600,000	600,000
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Series C Preferred Stock
Preferred Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized	540,000	540,000
Preferred Stock, Shares Issued	540,000	540,000
Preferred Stock, Shares Outstanding	540,000	540,000

XML

UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS
Revenue	$ 0	$ 0	$ 0	$ 0
Operating expenses:
Salaries and wages	45,000	45,000	135,000	135,000
Selling, general and administrative	6,642	1,950	20,730	6,963
Professional and legal fees	29,354	0	102,533	70,631
Total operating expenses	80,996	46,950	258,263	212,594
Loss from operations	(80,996)	(46,950)	(258,263)	(212,594)
Other expense:
Interest expense	(13,067)	(6,645)	(33,330)	(17,766)
Total other expense	(13,067)	(6,645)	(33,330)	(17,766)
Net loss	$ (94,063)	$ (53,595)	$ (291,593)	$ (230,360)
Net loss per common share - basic and diluted	$ (0.00)	$ (0.00)	$ (0.00)	$ (0.00)
Weighted average number of shares outstanding - basic and diluted	1,533,317,059	1,337,142,196	1,500,533,176	1,196,382,752

XML

UNAUDITED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS DEFICIT - USD ($)	Total	Series A Preferred Stock [Member]	Series C Preferred Stock [Member]	Common Stock	Additional Paid-In Capital	Retained Earnings (Accumulated Deficit)
Balance, shares at Dec. 31, 2019		1,000,000	540,000	1,153,317,059
Balance, amount at Dec. 31, 2019	$ (339,910)	$ 100	$ 54	$ 115,332	$ 2,657,844	$ (3,113,240)
Preferred Stock Series A conversion to common, shares		(4,600)		230,000,000
Preferred Stock Series A conversion to common, amount	0	$ 0	0	$ 23,000	(23,000)	0
Net loss	(230,360)	$ 0	$ 0	$ 0	0	(230,360)
Balance, shares at Sep. 30, 2020		995,400	540,000	1,383,317,059
Balance, amount at Sep. 30, 2020	(570,270)	$ 100	$ 54	$ 138,332	2,634,844	(3,343,600)
Balance, shares at Jun. 30, 2020		998,000	540,000	1,253,317,059
Balance, amount at Jun. 30, 2020	(516,675)	$ 100	$ 54	$ 125,332	2,647,844	(3,290,005)
Preferred Stock Series A conversion to common, shares		(2,600)		130,000,000
Preferred Stock Series A conversion to common, amount	0	$ 0	0	$ 13,000	(13,000)	0
Net loss	(53,595)	$ 0	$ 0	$ 0	0	(53,595)
Balance, shares at Sep. 30, 2020		995,400	540,000	1,383,317,059
Balance, amount at Sep. 30, 2020	(570,270)	$ 100	$ 54	$ 138,332	2,634,844	(3,343,600)
Balance, shares at Dec. 31, 2020		993,400	540,000	1,483,317,059
Balance, amount at Dec. 31, 2020	(686,093)	$ 100	$ 54	$ 148,332	2,624,844	(3,459,423)
Preferred Stock Series A conversion to common, shares		(1,000)		50,000,000
Preferred Stock Series A conversion to common, amount	0	$ (1)	0	$ 5,000	(4,999)	0
Net loss	(291,593)	$ 0	$ 0	$ 0	0	(291,593)
Balance, shares at Sep. 30, 2021		992,400	540,000	1,533,317,059
Balance, amount at Sep. 30, 2021	(977,686)	$ 99	$ 54	$ 153,332	2,619,845	(3,751,016)
Balance, shares at Jun. 30, 2021		992,400	540,000	1,533,317,059
Balance, amount at Jun. 30, 2021	(883,623)	$ 99	$ 54	$ 153,332	2,619,845	(3,656,953)
Net loss	(94,063)	$ 0	$ 0	$ 0	0	(94,063)
Balance, shares at Sep. 30, 2021		992,400	540,000	1,533,317,059
Balance, amount at Sep. 30, 2021	$ (977,686)	$ 99	$ 54	$ 153,332	$ 2,619,845	$ (3,751,016)

XML

UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (291,593)	$ (230,360)
Change in operating assets and liabilities:
Prepaid expenses	(7,000)	0
Accounts payable and accrued expenses	111,846	147,432
Net cash used in operating activities	(186,747)	(82,928)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of notes payable	161,083	59,713
Advances from officer	25,664	23,215
Net cash provided by financing activities	186,747	82,928
NET CHANGE IN CASH	0	0
Cash at beginning of year	0	0
CASH AT END OF YEAR	0	0
SUPPLEMENTAL DISCLOSURE FOR OPERATING ACTIVITIES:
Cash paid for interest	0	0
Cash paid for income taxes	0	0
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Preferred Stock Series A conversion to common stock	$ 5,000	$ 23,000

XML

INCORPORATION AND OPERATIONS

9 Months Ended

Sep. 30, 2021

INCORPORATION AND OPERATIONS

NOTE 1 - INCORPORATION AND OPERATIONS

NOTE 1 – INCORPORATION AND OPERATIONS

Integrated Cannabis Solutions, Inc. (the “Company”) is a Nevada corporation quoted  on OTC Markets Pink under the ticker "IGPK" . The Company was formed on December 31, 2003 and had nominal operations during the years ended December 31, 2020 and 2019.

The Company plans to process hemp or biomass into Cannabidiol (“CBD”) by establishing a processing plant in Wisconsin to supply manufacturers or pharmaceutical companies for their manufacture, distribution and sale of CBD related products such as edibles for human consumption, vitamins, and multi-vitamins, and topical products for human use such as oils, tinctures, creams, oils and salves, and vaping liquids. The Company also plans to promote and assist in the establishment of a co-op with local farmers for the purpose of establishing a consistent supply of biomass and enter into long term supply contracts.

On May 21, 2019, the Company formed Integrated Farming Solutions, LLC,  a limited liability company in Nevada. Integrated Farming Solutions, LLC is the Company’s wholly-owned subsidiary and has not yet begun operations. No assurance can be provided that the Company will be successful in implementing and executing on its business plans.

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION

9 Months Ended

Sep. 30, 2021

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION

The accompanying unaudited interim consolidated financial statements of Integrated Cannabis Solutions, Inc. (the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America and should be read in conjunction with the audited financial statements and notes thereto. In the opinion of management, such statements reflect all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of the condensed financial statements of the Company as of September 30, 2021 and for the three and nine months ended September 30, 2021 and 2020. The results of operations for the nine months ended September 30, 2021 are not necessarily indicative of the results to be expected for the full year the full year ending December 31, 2021 or any other period. These unaudited condensed financial statements should be read in conjunction with the audited financial statements and related disclosures of the Company as of December 31, 2020 and for the year then ended.

The accompanying unaudited interim condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiary. All intercompany balances and transactions have been eliminated in consolidation.

Accounting method and use of estimates

The Company’s financial statements are prepared using the accrual method in accordance with Generally Accepted Accounting Principles in the United State of America (“GAAP”). The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Changes in estimates and assumptions are reflected in reported results in the period in which they become known. Significant estimates made by management include, but are not limited to, valuation of stock options, stock-based compensation, convertible debt and the valuation allowance associated with deferred tax assets. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. Actual results could differ from those estimates.

Loss per Share

In accordance with the provisions of ASC 260, “Earnings Per Share”, net loss per share is computed by dividing net loss by the weighted-average shares of common stock outstanding during the period. During a loss period, the effect of the potential exercise of stock options and convertible debt are not considered in the diluted loss per share calculation since the effect would be anti-dilutive. The results of operations were a net loss for the three and nine months ended September 30, 2021 and 2020, therefore, the basic and diluted weighted-average shares of common stock outstanding were the same for all years. The anti-dilutive shares of common stock outstanding as of September 30, 2021 and 2020 were as follows:

	September 30,
	2021		2020
Potentially dilutive securities:
Series A Preferred Stock		49,670,000,000		49,900,000,000
Series C Preferred Stock		137,755,102		446,280,992

Recent Accounting Pronouncements

The Company has implemented all new accounting pronouncements that are in effect and that may impact its consolidated financial statements. The Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

XML

GOING CONCERN

9 Months Ended

Sep. 30, 2021

GOING CONCERN

NOTE 3 - GOING CONCERN

NOTE 3 – GOING CONCERN

At September 30, 2021, the Company had a working capital deficit of $977,686 and has yet to commence its plan of operations. The Company’s current liquidity resources are insufficient to fund its anticipated level of operations for at least the next 12 months from the date these financial statements were issued. As a result, there is substantial doubt regarding the Company’ ability to continue as a going concern.

The Company’s ability to continue operations depends on its ability to generate and grow revenue and results of operations as well as its ability to access capital markets when necessary to accomplish its strategic objectives. The Company expects that it will continue to incur losses for the immediate future and will need additional equity or debt financing until the Company can achieve profitability and positive cash flows from operating activities. The Company’s future capital requirements for its operations will depend on many factors, including the ability to generate revenues and its ability to obtain capital. There is no assurance that the Company will be successful in any capital-raising efforts that it may undertake to fund operations and implement its business plan in the future.

XML

ACCOUNTS PAYABLE AND ACCRUED EXPENSES

9 Months Ended

Sep. 30, 2021

ACCOUNTS PAYABLE AND ACCRUED EXPENSES

NOTE 4 - ACCOUNTS PAYABLE AND ACCRUED EXPENSES

NOTE 4 – ACCOUNTS PAYABLE AND ACCRUED EXPENSES

As of September 30, 2021 and December 31, 2020, accounts payable and accrued expenses consisted of the following:

	September 30,		December 31,
	2021		2020
Accounts payable	$	16,826	$	73,310
Accrued payroll		365,000		230,000
Accrued interest payable		74,273		40,943
Total	$	456,099	$	344,253

XML

RELATED PARTY TRANSACTIONS

9 Months Ended

Sep. 30, 2021

RELATED PARTY TRANSACTIONS

NOTE 5 - RELATED PARTY TRANSACTIONS

NOTE 5 – RELATED PARTY TRANSACTIONS

The Company’s Chief Executive Officer (“CEO”) advanced $25,664 by paying expenses on behalf of the Company during the nine months ended September 30, 2021 for working capital purposes. The Company accrues $500 per month for rent and use of the CEO’s office space. The loans bear interest at 10% per annum and are payable on demand. The balance of the loans were $136,168 and $110,504 and accrued interest was $26,010 and $17,168 as of September 30, 2021 and December 31, 2020, respectively. Interest expense was $8,843 and $6,955 for the nine months ended September 30, 2021 and 2020, respectively.

XML

NOTES PAYABLE

9 Months Ended

Sep. 30, 2021

NOTES PAYABLE

NOTE 6 - NOTES PAYABLE

NOTE 6 – NOTES PAYABLE

During the nine months ended September 30, 2021, a third party lender advanced a total of $153,583 for working capital purposes under a demand note. The advances accrue interest at 10% per annum and are due on demand. The balance on the note was $387,919 and $234,336 and accrued interest was $47,819 and $23,775 as of September 30, 2021 and December 31, 2020, respectively. Interest expense was $24,043 and $10,810 for the nine months ended September 30, 2021 and 2020, respectively.

During the nine months ended September 30, 2021, a third party lender advanced a total of $7,500 for working capital purposes under a demand note. The advance accrues interest at 10% per annum and is due on demand. The balance on the note was $7,500 and accrued interest was $444 as of September 30, 2021. Interest expense was $444 for the nine months ended September 30, 2021.

XML

COMMITMENTS AND CONTINGENCIES

9 Months Ended

Sep. 30, 2021

COMMITMENTS AND CONTINGENCIES

NOTE 7 - COMMITMENTS AND CONTINGENCIES

NOTE 7 – COMMITMENTS AND CONTINGENCIES

The Company from time to time is party to certain lawsuits, legal proceedings and various claims relating to matters in the normal course of its business. Liabilities for such matters are accrued when it is probable that a liability has been incurred and the amount can be reasonably estimated. When only a range of possible loss can be established, the most probable amount in the range is accrued. If no amount within this range is a better estimate than any other amount within the range, the minimum amount in the range is accrued. The accrual for a litigation loss contingency might include, for example, estimates of potential damages, outside legal fees and other directly related costs expected to be incurred. As of September 30, 2021, and through the date these financial statements were issued, there were no legal proceedings requiring recognition or disclosure in the unaudited condensed consolidated financial statements.

On January 1, 2018, the Company entered into an employment agreement with the CEO. Under the terms of the employment agreement, the Company was to pay the CEO a salary at a rate of $180,000 for the 2018 calendar year, $300,000 for the 2019 calendar year, and $500,000 for the 2020 calendar year. On December 31, 2019, the CEO’s salary was reduced to $180,000 per year effective on January 1, 2020 and the aggregate of previously accrued wages were reduced to $50,000 in total.

The Company has accrued $365,000 and $230,000 as of September 30, 2021 and December 31, 2020, respectively, and recognized $135,000 and $135,000 in wage expense for the nine months ended September 30, 2021 and 2020, respectively.

On February 23, 2021, the Company and our Chief Executive Officer were served with a Complaint in the Superior Court for Sacramento, California alleging negligence and premises liability by over 100 persons and entities. The complaint has no merit and we intend to vigorously defend the matter. 

XML

COMMON STOCK

9 Months Ended

Sep. 30, 2021

COMMON STOCK

NOTE 8 - COMMON STOCK

NOTE 8 – COMMON STOCK

During the nine months ended September 30, 2021 and 2020, a holder of 1,000 and 2,000 shares of our Preferred Series A stock converted those shares into 50,000,000 and 100,000,000 shares of the Company’s common stock, respectively.

XML

SUBSEQUENT EVENTS

9 Months Ended

Sep. 30, 2021

SUBSEQUENT EVENTS

NOTE 9- SUBSEQUENT EVENTS

NOTE 9 – SUBSEQUENT EVENTS

The Company has evaluated subsequent events for financial statement purposes, there were none occurring through the date these financial statements were ready for issuance, that require disclosure in these consolidated financial statements.

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION (Policies)

9 Months Ended

Sep. 30, 2021

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION

Accounting method and use of estimates

The Company’s financial statements are prepared using the accrual method in accordance with Generally Accepted Accounting Principles in the United State of America (“GAAP”). The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Changes in estimates and assumptions are reflected in reported results in the period in which they become known. Significant estimates made by management include, but are not limited to, valuation of stock options, stock-based compensation, convertible debt and the valuation allowance associated with deferred tax assets. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. Actual results could differ from those estimates.

Loss per Share

In accordance with the provisions of ASC 260, “Earnings Per Share”, net loss per share is computed by dividing net loss by the weighted-average shares of common stock outstanding during the period. During a loss period, the effect of the potential exercise of stock options and convertible debt are not considered in the diluted loss per share calculation since the effect would be anti-dilutive. The results of operations were a net loss for the three and nine months ended September 30, 2021 and 2020, therefore, the basic and diluted weighted-average shares of common stock outstanding were the same for all years. The anti-dilutive shares of common stock outstanding as of September 30, 2021 and 2020 were as follows:

	September 30,
	2021		2020
Potentially dilutive securities:
Series A Preferred Stock		49,670,000,000		49,900,000,000
Series C Preferred Stock		137,755,102		446,280,992

Recent Accounting Pronouncements

The Company has implemented all new accounting pronouncements that are in effect and that may impact its consolidated financial statements. The Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION (Tables)

9 Months Ended

Sep. 30, 2021

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION

Summary of anti-dilutive shares of common stock outstanding

	September 30,
	2021		2020
Potentially dilutive securities:
Series A Preferred Stock		49,670,000,000		49,900,000,000
Series C Preferred Stock		137,755,102		446,280,992

XML

ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)

9 Months Ended

Sep. 30, 2021

ACCOUNTS PAYABLE AND ACCRUED EXPENSES

Summary of accounts payable and accrued expenses

	September 30,		December 31,
	2021		2020
Accounts payable	$	16,826	$	73,310
Accrued payroll		365,000		230,000
Accrued interest payable		74,273		40,943
Total	$	456,099	$	344,253

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION (Details) - shares	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Series A Preferred Stock
Potentially dilutive securities	49,670,000,000	49,900,000,000
Series C Preferred Stock
Potentially dilutive securities	137,755,102	446,280,992

XML

GOING CONCERN (Details Narrative)	Sep. 30, 2021 USD ($)
GOING CONCERN
Working capital deficit	$ (977,686)

XML

ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details) - USD ($)	Sep. 30, 2021	Dec. 31, 2020
NOTES PAYABLE
Accounts payable	$ 16,826	$ 73,310
Accrued payroll	365,000	230,000
Accrued interest payable	74,273	40,943
Total	$ 456,099	$ 344,253

XML

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Accrued interest	$ 74,273		$ 40,943
Advances from officer	136,168		110,504
Chief Executive Officer [Member]
Interest expense	8,843	$ 6,955
Accrued interest	26,010		17,168
Advances from officer	136,168		$ 110,504
Expense paid by related party	25,664
Monthly rent for office space	$ 500
Loans interest rate	10.00%

XML

NOTES PAYABLE (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Accrued interest	$ 74,273		$ 40,943
Lender [Member] | Transaction One [Member]
Proceeds from notes payable	$ 153,583
Notes payable interest rate	10.00%
Accrued interest	$ 47,819		23,775
Notes payable	387,919		$ 234,336
Interest expense	24,043	$ 10,810
Lender [Member] | Transaction Two [Member]
Proceeds from notes payable	$ 7,500
Notes payable interest rate	10.00%
Accrued interest	$ 444
Notes payable	7,500
Interest expense	$ 444

XML

COMMITMENTS AND CONTINGENCIESCOMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Accrued payroll	$ 365,000		$ 365,000		$ 230,000
Salaries and wages	$ 45,000	$ 45,000	$ 135,000	$ 135,000
Chief Executive Officer [Member]
Salaries and wages					$ 500,000	$ 300,000	$ 180,000
Salary reduction description			On December 31, 2019, the CEO’s salary was reduced to $180,000 per year effective on January 1, 2020 and the aggregate of previously accrued wages were reduced to $50,000 in total

XML

COMMON STOCK (Details Narrative) - shares	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Common stock shares issued upon conversion of preferred stock	50,000,000	100,000,000
Series A Preferred Stock
Debt Conversion, Converted Instrument, Shares Converted	1,000	2,000